Cargando…
Insight into the Interactions between Novel Isoquinolin-1,3-Dione Derivatives and Cyclin-Dependent Kinase 4 Combining QSAR and Molecular Docking
Several small-molecule CDK inhibitors have been identified, but none have been approved for clinical use in the past few years. A new series of 4-[(3-hydroxybenzylamino)-methylene]-4H-isoquinoline-1,3-diones were reported as highly potent and selective CDK4 inhibitors. In order to find more potent C...
Autores principales: | Zheng, Junxia, Kong, Hao, Wilson, James M., Guo, Jialiang, Chang, Yiqun, Yang, Mengjia, Xiao, Gaokeng, Sun, Pinghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983096/ https://www.ncbi.nlm.nih.gov/pubmed/24722522 http://dx.doi.org/10.1371/journal.pone.0093704 |
Ejemplares similares
-
Docking and Antiherpetic Activity of 2-Aminobenzo[de]-isoquinoline-1,3-diones
por: Al-Salahi, Rashad, et al.
Publicado: (2015) -
3D-QSAR Studies on Thiazolidin-4-one S1P(1) Receptor Agonists by CoMFA and CoMSIA
por: Qian, Chuiwen, et al.
Publicado: (2011) -
New molecular insights into the tyrosyl-tRNA synthase inhibitors: CoMFA, CoMSIA analyses and molecular docking studies
por: Li, Shengrong, et al.
Publicado: (2017) -
Benzo[de]isoquinoline-1,3-dione condensed asymmetric azaacenes as strong acceptors
por: Zhou, Pengxin, et al.
Publicado: (2022) -
2-(Benzyloxy)isoquinoline-1,3(2H,4H)-dione
por: Ishikawa, Yoshinobu, et al.
Publicado: (2013)